Research ArticleINFLAMMATION

Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases

See allHide authors and affiliations

Science Immunology  30 Apr 2021:
Vol. 6, Issue 58, eabe2933
DOI: 10.1126/sciimmunol.abe2933

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Immunology

Navigate This Article